Skip to main content
Premium Trial:

Request an Annual Quote

Australian Research Council Funds ‘Omics Studies at Hall Institute

NEW YORK (GenomeWeb News) – The Australian Research Council has awarded several new grants to researchers at the Walter and Eliza Hall Institute in Melbourne to pursue genetic and genomic studies aimed at breast cancer, inflammatory diseases, and chronic pain.

The ARC Discovery Project grants on average provide around AU$116,000 ($105,000) per year over three years. Three of the Hall Institute researchers to receive ARC funding also won QEII Fellowships, which are funded over five years.

The studies will include a collaboration with LaTrobe University that will focus on the role of a protein in cancer, and a collaboration with the University of Melbourne that will study small molecule structures and protein interactions involved in diseases.

Another Hall Institute study will explore genes that shut off immune responses, and another will seek to identify genes involved in breast cancer progression.

"From research into the epigenetic modifiers that control whether our genes are switched off or on to developing an understanding of what goes wrong with our immune systems to allow inflammatory diseases such as rheumatoid arthritis and psoriasis to occur, our scientists are striving to find the causes, treatments, and cures that will benefit people worldwide," Hall Institute Director Doug Hilton said in a statement.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.